CATEGORIES

Discover Drugs

LATEST

TRENDING

EDITORS CHOICE

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

Opdivo® Approved for the Treatment of Advanced Esophageal Squamous Cell Carcinoma

FDA Approved Opdivo demonstrated superior overall survival benefit compared to docetaxel or paclitaxel in ESCC Patients

Oriahnn; A Drug to Stop Heavy Periods for Women With Fibroids

Oriahnn™ comes packaged as a daily oral medication giving women the options to avoid surgery, procedure, or a birth control method.